Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.
about
Blood transcriptomics and metabolomics for personalized medicineMetabolomic biomarkers as strong correlates of Parkinson disease progressionSequencing the exposome: A call to action.Plasma metabolomics in human pulmonary tuberculosis disease: a pilot studyImproved drug therapy: triangulating phenomics with genomics and metabolomics.Novel metabolic markers for the risk of diabetes development in American Indians.Metabolomics of ADSOL (AS-1) red blood cell storageHonokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research.High-Resolution Metabolomics: Review of the Field and Implications for Nursing Science and the Study of Preterm BirthPlasma Metabolomics of Common Marmosets (Callithrix jacchus) to Evaluate Diet and Feeding HusbandryPharmacological chaperone design for reducing risk factor of Parkinson's disease from traditional chinese medicine.Computational Metabolomics: A Framework for the Million Metabolome.Recent advances in biomarkers for Parkinson's disease focusing on biochemicals, omics and neuroimaging.Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.Deployment-Associated Exposure Surveillance With High-Resolution Metabolomics.Amyloid misfolding, aggregation, and the early onset of protein deposition diseases: insights from AFM experiments and computational analyses.Identification of novel biomarkers for Parkinson's disease by metabolomic technologies.Plasma metabolomics reveals membrane lipids, aspartate/asparagine and nucleotide metabolism pathway differences associated with chloroquine resistance in Plasmodium vivax malariaA metabolomic study on high-risk stroke patients determines low levels of serum lysine metabolites: a retrospective cohort study.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.High-Resolution Metabolomics Assessment of Military Personnel: Evaluating Analytical Strategies for Chemical Detection.Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease.From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.A glimmer of light at the end of the tunnel?Metabolomics toward personalized medicine.Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.Putrescine as indicator of manganese neurotoxicity: Dose-response study in human SH-SY5Y cells.
P2860
Q26772073-E774A5D5-3686-49D2-9E80-F677BB4FFA4FQ29248111-B56D678A-FC43-4AB0-87FE-8AAD8D97762DQ30692583-E493914C-DA30-4567-9731-3488EBEE40F3Q34343488-AE99C4AD-6E37-42DD-BF5C-3938C45BAEBFQ34436487-CDB1D140-8565-45F4-B6E8-6B3B3C394D77Q34996866-DFC1FFD1-83DD-4F06-B1EB-F99B30AAF11EQ35122576-EEB86552-6DDA-4FF1-9850-9D10D28A6469Q35636476-A1B4876D-B9C5-4F89-98AB-0BE243A35D65Q36363433-878A1433-AE1A-4BC7-A70A-99ADBA09110FQ36387102-1C7A7B8F-0394-4B16-BFA2-5FAAE8822712Q36666258-5A17541B-C1D0-4F9A-A1F8-984872E10127Q37556518-EADD95B6-EEFD-4FD9-8DB9-C4865A6171B6Q37733172-BA7E77E3-EFF8-411F-B403-EB25AEA95005Q38315590-614D6D2A-A4E9-4284-9E29-B8B470F7E7F2Q38639708-3284A6C6-3298-4ABD-BC45-B68149E4C284Q38719357-565A3B39-8716-4BC6-AA72-3DDD528AAD55Q38921721-6AD91522-DEE5-405C-A4A0-BEFE04F02277Q39004129-DD64CC42-E488-4D6C-A43A-7F8B6B49A295Q39026922-CBE480C7-31D5-45F8-A97A-2A710EB905F2Q39543705-116CA128-A3CB-4279-83D2-DC9DE8835486Q40233532-71C5EBD1-EB62-4BAD-B63C-0291A45567C2Q41666702-D697C1D0-D542-4E58-A442-861A207A89B6Q42370974-3ED8F109-6909-4A64-B145-28BC98D8FF37Q48320615-55EBA517-5AB2-41E9-8E70-6C9E86AC712CQ49197356-7C5746E4-8135-4F11-9FDE-50C578020ADBQ50045364-878ECD28-C510-443E-BAF6-8A3131E6B7D8Q50090010-12530E8B-EFED-4A35-BC8B-F6C5B6BCC9E9Q51761574-B5BAA2D5-79AF-4E41-8B0A-A4EFFCCCE0B6Q52691697-DEB50D29-EF1D-42D1-B8ED-B1D92989BEFF
P2860
Serum metabolomics of slow vs. rapid motor progression Parkinson's disease: a pilot study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Serum metabolomics of slow vs. ...... nson's disease: a pilot study.
@ast
Serum metabolomics of slow vs. ...... nson's disease: a pilot study.
@en
type
label
Serum metabolomics of slow vs. ...... nson's disease: a pilot study.
@ast
Serum metabolomics of slow vs. ...... nson's disease: a pilot study.
@en
prefLabel
Serum metabolomics of slow vs. ...... nson's disease: a pilot study.
@ast
Serum metabolomics of slow vs. ...... nson's disease: a pilot study.
@en
P2093
P2860
P50
P1433
P1476
Serum metabolomics of slow vs. ...... nson's disease: a pilot study.
@en
P2093
Dean P Jones
Douglas Walker
Frederick H Strobel
James R Roede
Kichun Lee
Shannon L Rhodes
Vilinh Tran
P2860
P304
P356
10.1371/JOURNAL.PONE.0077629
P407
P577
2013-10-22T00:00:00Z